In this study, we found that the patients of both myelodysplastic syndromes and chronic myeloid leukaemia with BMI1 overexpression had a higher risk in malignant myeloid progression. Here, BMI1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.